| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3671 | |||||||||||||||||||||||
| Submitter : | Mr. Thomas Kinney | Date & Time: | 12/19/2006 09:12:49 | |||||||||||||||||||||
| Organization : | Knights of Columbus | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I do not agree with using cells from aborted fetuses for doing research on pharmaceutical products. I believe cells should be harvested from alternative sources. | ||||||||||||||||||||||||